Skip to main content
. 2021 Dec 11;229:114046. doi: 10.1016/j.ejmech.2021.114046

Scheme 1.

Scheme 1

a) carboxylic acid (1.0 mmol, 1.0 eq.), 4-tert-butylaniline (1.0 mmol, 1.0 eq.), 3-pyridinecarboxaldehyde (1.0 mmol, 1.0 eq.), cyclohexyl isocyanide (0.9 mmol, 0.9 eq.), MeOH (5 mL, 0.2 M), r.t., overnight, X77 (30%), ML188 (84%), 4a (76%), 6a (32%), 7a (94%), 8a (32%), 9a (73%), 10a (68%), 11a (80%), 12a (37%), 13a (92%), 15a (70%), 16a (93%), 17a (52%), 18a (36%), 20a (84%), 21a (68%), 22a (29%), 23a (43%), 8b (54%), 13b (82%), 6b (42%), 4b (84%), 13c (94%), 13d (86%), 16b (88%), 16c (91%), 11b (67%), 11c (79%), 11d (59%), 11e (26%), 11f (71%), 11g (29%), 11h (78%), 11i (37%), 8c (74%), 16d (87%), 16f (34%), 13e (90%), 13f (69%), 13g (91%), 13h (92%), 13i (22%), 13j (47%), 18b (37%), 13k (83%), 13l (57%), 13m (82%), 13n (89%), 13o (88%), 13p (89%), 13q (35%). b) 3-pyridinecarboxaldehyde (2.0 mmol, 2.0 eq.), glycinamide hydrochloride (2.0 mmol, 2.0 eq.), triethylamine (2.0 mmol, 2.0 eq.), acetic acid (2.0 mmol, 2.0 eq.), cyclohexyl isocyanide (2.0 mmol, 2.0 eq.), MeOH (5 mL, 0.2 M), r.t., overnight, 24a (79%). c) 3-pyridinecarboxaldehyde (1.0 mmol, 1.0 eq.), β-alanine (1.0 mmol, 1.0 eq.), cyclohexyl isocyanide (1.0 mmol, 1.0 eq.), MeOH (5 mL, 0.2 M), r.t., overnight, 25a (54%). D) phosphoric acid, MeOH, r.t., 68%.